Tech's selloff grabbed headlines. A quieter rotation into small caps and healthcare tells a different story. The data supports a broadening market, not the start of a decline.
Alpha Score of 27 reflects poor overall profile with poor momentum, poor value, moderate quality, poor sentiment.
Last week's tech selloff grabbed the headlines. The Nasdaq Composite fell more than 2%, dragged lower by megacap tech stocks. That headline obscured a quieter rotation that delivered gains in healthcare and small caps.
The Russell 2000 index of small-cap stocks gained about 1% over the same period. Healthcare stocks in the S&P 500 rose roughly 0.5%. The divergence suggests money is moving out of the crowded tech trade into parts of the market that had lagged for months.
Two factors drove the shift. First, the Federal Reserve's latest dot plot reinforced the view that rates will stay higher for longer. Tech valuations, already stretched, became harder to justify when future cash flows face a higher discount rate. Second, earnings season showed a broadening of profit growth beyond the Magnificent Seven. Companies in healthcare and financials beat estimates at a higher rate than tech in the most recent quarter, according to FactSet data.
Small caps benefit from a different dynamic. Many carry floating-rate debt, meaning a sustained period of elevated rates normally hurts them more than large caps. The Russell 2000's recent rally suggests investors expect the economy to avoid a sharp slowdown. Small-cap earnings revisions have turned positive for the first time since early 2022, according to FactSet. Small caps tend to lead in the early stages of an economic recovery.
The bears focus on tech weakness as a warning. The Nasdaq's drop last week followed a pattern seen before corrections: a narrow rally that runs out of steam. The small-cap and healthcare gains tell a different story. When money rotates rather than exits the market entirely, the selloff becomes a sector rotation, not the start of a broad decline.
The speed of small-cap gains introduces risk. The Russell 2000 has already recovered from its October lows and trades near the upper end of its post-2021 range. Further gains would need earnings to keep improving. The next test comes in July, when second-quarter reports start. If small-cap earnings confirm the upward trend, the rotation has room to run. If they disappoint, the move could reverse quickly.
Prepared with AlphaScala research tooling and grounded in primary market data: live prices, fundamentals, SEC filings, hedge-fund holdings, and insider activity. Each story is checked against AlphaScala publishing rules before release. Educational coverage, not personalized advice.